By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over the last 12 months, three Opko Health, Inc. company insiders bought into shares in open-market trades, about $3.2 million in total, and none of them sold.
The largest purchase came from Frost Gamma Investments Trust (CEO), about $282,000. C-suite participation is part of the picture here.
223 investment managers listed OPK in their latest 13F filings (Q2 2026); more funds bought than sold. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 5 of the last 7 full quarters.
Are insiders buying or selling OPK stock?
In the last 12 months Opko Health, Inc. insiders made open-market purchases worth about $3.2 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in OPK?
The most recent open-market insider trade in OPK was filed on 2026-03-20.
How many institutions own OPK?
223 investment managers reported holding OPK in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded OPK?
No congressional trades in OPK were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).